Drug resistance among top threats: WHO
NEW DELHI: Antimicrobial Resistance (AMR) has been identified as one of the 10 threats to global health in 2019 by World Health Organisation (WHO). The other threats on this list include HIV, Ebola, dengue,
Drugs
-
Health ministry mulled compulsory licencing of rare disease drugs
NEW DELHI: The health ministry was actively mulling compulsory licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the department of pharmaceuticals abruptly issued an order
-
President orders plan to alleviate poverty
President Maithripala Sirisena has ordered officials to prepare a plan in the new year to alleviate poverty in the country. Addressing public officials at the Polonnaruwa District Secretariat, the President
-
DR Congo begins first-ever multi-drug Ebola trial
The Ministry of Health of the Democratic Republic of the Congo (DRC) today announced that a randomized control trial has begun to evaluate the effectiveness and safety of drugs used in the treatment of
-
Top drugmakers not doing enough to provide medicines to poor countries: Report
Many of the world's top drugmakers are not doing enough to provide medicines to poor countries, leaving big gaps in access to treatments in crucial disease areas, including cancer, according to a new report
-
Clinical trial of injectable ARV drug starts in Uganda
Uganda has started recruiting women for trials of a long-lasting injectable antiretroviral drug for Pre-Exposure Prophylaxis. This is part of a large scale trial that will also be conducted in six other
-
Access to medicine index 2018
The Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. The development of new medical products that are considered
-
Introduction and geographic availability of new antibiotics approved between 1999 and 2014
<p>Despite the urgent need for new, effective antibiotics, few antibiotics of value have entered the market during the past decades. Therefore, incentives have been developed to stimulate antibiotic R&D.
-
Order of the Supreme Court of India regarding Drug Price Control Order 2013, 10/10/2018
<p>Order of the Supreme Court of India in the matter of All India Drug Action Network & Others Vs Union of India & Others dated 10/10/2018 regarding Drug Price Control Order 2013. <a href="http://www.indiaenvironmentportal.org.in/files/file/drug_price_controlOrder_10-Oct-2018.pdf"
-
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial
<p>The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa,<a href="http://www.indiaenvironmentportal.org.in/files/file/onchocerciasis_infection_Africa.pdf"